Nevertheless, combinations of IFN-α/AZT or IFN-α/AZT/arsenic trioxide represent efficient means to obtain complete remission in most ATLL subtypes (except the lymphoma type) and in the murine ATLL model. This evidence concerns the gene IFNA1 and lymphoma.